COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES: Pharm Control Ltd.: Pharm Control Announces Formation of New Marketing and Distribution Unit
May 04, 2007 (M2 PRESSWIRE via COMTEX) -- Pharm Control Ltd. (NASDAQ OTHER OTC: PMCL) is pleased to announce that after discussions with European investment bankers, the Company has decided to form a new corporation called Natural Medicines AG, which will serve as the Company's marketing and distribution arm of in Europe.
The Company intends to spin off by way of stock dividend ownership of this new entity to its shareholders. This will be done after the Company makes the necessary arrangements to list this company on a European stock exchange in the coming months.
Further information including dividend dates will be forthcoming.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
-0-
Search for Dun & Bradstreet reports on this company.
-------------------- ~You aren't wealthy until you have something money can't buy.~ Posts: 3070 | From: CT | Registered: Apr 2006
| IP: Logged |
posted
************ Report ************ picks 4 speculations for May 2007
Recent ************ picks have made considerable gains since our last reporting. IAO (AMEX) closed at 57 cents on Friday May 4, 2007 up 307% since we picked it on January 7. DIMEZ is up 100% since our last report. We believe IAO and DIMEZ still have considerable upside potential in the near future. Also, CSYS going nowhere since our report has the potential to be the sleeper stock of the year… in our opinion.
Pharm Control Ltd. (OTC: PMCL)
Pharm Control Ltd. is focused on the development of natural, no side effect supplements to cure diseases such as diabetes, high blood pressure and high cholesterol related sicknesses, digestive disorders, liver and kidney diseases. The first product in the development pipeline is Control 24 ®, a natural product that is focused on the diabetes and pre-diabetes market.
Diabetes is the third leading cause of death in the U.S. after heart disease and cancer. It is a disease in which the body does not produce or properly use insulin necessary for the body to metabolize glucose (sugar). The glucose stays in your blood instead and its level then gets too high, causing you to have diabetes. Diabetes affects an estimated 20 million people in the United States with another 15 million not yet diagnosed with an economic cost of over $100 billion yearly. Globally, the costs are staggering.
Western medicine prescribes lifestyle changes, medications, and daily blood tests for life since there is no cure, only treatments to control it and delay its devastating affects. Over time, complications from diabetes can lead to blindness, kidney failure, heart disease, nerve damage, and limb amputations. Current medications can have serious side-effects including anxiety or nervousness, confusion, difficulty concentrating; blurred vision; breathing problems such as rapid, deep breathing or difficulty breathing with activity; cold sweats, increased sweating; cool, pale skin; dark yellow or brown urine, or yellowing of the eyes or skin; diarrhea; drowsiness; muscle pain; nausea, vomiting; rapid gain in weight; skin rash or hives; slow heartbeat; tremors or shakiness; unusual tiredness or weakness; swelling of the hands, legs, and/or feet.
Pharm Control Ltd. believes blood sugar can be maintained at healthy levels by pure Oriental medicine. Control 24 ® cleans the impure thick blood and as the result the liver become more efficient and the cholesterol level goes down as the result. According to the company, western medicine stimulates the pancreas resulting in the damage to the organ. It can completely destroy the pancreatic function and the patients have to rely on insulin. On the other hand Oriental diabetic medicine Control 24 ® aims at curing the cause of diabetes. Control 24 ® when taken in gradually decreasing amount makes the normal daily life possible.
Diabetes, whether it is in early or chronic stage, manifests itself with fever. According to the Oriental medicine the general causes of diabetes are lung fever, stomach fever and kidney fever. They are believed to be affected by liver fever. This fever goes into blood stream and make blood impure and thick. For this reason, Oriental medicines for diabetes always contain compounds which clean the blood. The popular ingredients for that purpose are such as Rehmannia root, lotus root, mouse eye bean (Rhynchosia phaseoloides), red ginseng and garlic extract.
Wasp's Nest (Nidus vespa), Jerusalem artichoke (Helianthus tuberosus), ten-thousand-year mushroom (Ganoderam lucidum), Korean Mulberry (Morus australis) are some other components of the Oriental diabetic medicines. These gradually restore the pancreatic function without complication, stabilize blood sugar level and clean the blood.
Control 24 ® can achieve not only normalization of blood sugar but also cure the ailment through systemic management of diet, exercise and life-style. By curing the ailment it is possible to have normal life without life-long dependency on drugs.
Control 24 ® is clinically proven to have no side effects and is guaranteed to be 100% effective.
The key to Control 24 ® effectiveness lies in its secret blend of botanical ingredients combined from over ten years of laboratory trials and immuno-pharmacological research. Every ingredient plays its particular role and the botanical blend as a whole represents a powerful tool to normalize your blood sugar levels. Control 24 ® is a breakthrough in scientific research and works at the cellular level in stages as follows:
1. Reduces blood sugar levels: Control 24 ® interferes with glucose absorption from the intestine and prevents adrenal hormones from stimulating the liver to produce glucose, both of which directly reduce blood sugar levels.
2. Eliminates insulin resistance: Control 24 ® repairs cell receptors to better recognize insulin which virtually eliminates insulin resistance. Most medical sources agree that insulin resistance is the root cause of Type 2 diabetes. Cells are now much more successful at metabolizing glucose which further normalizes blood sugar levels.
3. Promotes insulin production: Control 24 ® stimulates the increased production of an organic compound that is naturally produced by the body. If you are Type 2, it is quickly converted to insulin by the pancreas for increased insulin output. If you are Type 1, this conversion is not possible due to destroyed beta cells. Instead, this organic compound remains and functions just like insulin as a natural alternative. With increased production over time, stress on the pancreas is relieved which allows it to naturally heal and develop new beta cells with a different signature. These new beta cells are not susceptible to the body's immune system malfunction.
Pharm Control recently announced it has made an application and has had preliminary talks with Wal-Mart to become a new supplier. http://biz.yahoo.com/iw/070124/0206988.html
PMCL traded 10 million shares on above average volume Friday May 4, 2007. PMCL closed at 1.6 cents. Approximately 66 million shares outstanding with insiders owning almost half. If a definitive agreement is signed with Wal-Mart to sell its natural healing products watch for shares of PMCL to move north… fast!
posted
5/7/2007 9:54:33 AM ET PMCL BUY xxxxxx PMCL * $0.015Completed Executed
go PMCL!!
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
PMCL PMCL -- Pharm Control Ltd. Com (1 Cent) Search for Dun & Bradstreet reports on this company. Address: 47 Redwillow Drive Toronto, ONT M3A 2K8 CAN Website: http://www.control24.114toronto.com/ Phone: 212-252-4521 Fax: 416-391-3802 Business Description: Company manufactures and distributes natural products and in particular natural solution to diabetes. Primary State of Incorporation: Delaware Country of Incorporation: USA Officers: Dr. Sang Hee Lee, President/CEO; Ho Sup Song, Secretary/Treasurer; Jae Ho Kim, Vice President/Dir.; Eugene Kron, Vice President; Yevgen Konaryev, Vice President/Dir. Fiscal Year End: April CIK: 0001015457
-------------------------------------------------------------------------------- -------------------------------------------- http://www.qwoter.com/profiles/item.php?id=34&dir=1 ( for complete info use this link )
Pharm Control Ltd. Spam Rating (0/5) Spam Report Why is this report useful to the investor? By using this PMCL Spam Report, the common investor will now have an information tool in which to make a more informed investment decision, whether the investor chooses to catch the wave early or to stay away from a "too good to be true" stock scam, at least he or she will have a better map of the terrain surrounding their investment decision. Read a more detailed explanation of why this spam report is important. Every effort is made to ensure that the information on this page is accurate. If you represent this company and you feel that this entry is incorrect in any way, please contact us. » View the latest stock spam list.
[ Close Box ] No spam reported. Overview The Pharm Control Ltd. (Pinksheet: PMCL) of Canada is a leading All Natural and Oriental medicine research and development company, which is devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. Its founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in modern world. Pharm Control Ltd. is devoted to discovering and developing new medicines that will enable patients to live longer, healthier and more productive lives. Pharm Control Ltd. mission is to develop natural and no side effect supplement to cure diseases such as Diabetes, High Blood and high Cholesterol related sickness, Digestive Disorders, Liver and Kidney diseases. Pharm Control Ltd. believes that balance of the human body system can cure any type of diseases naturally. Symbol PMCL Outstanding Shares 40,832,508 as of 2006-12-12 Officers Dr. Sang Hee Lee, President/CEO; Ho Sup Song, Secretary/Treasurer; Yevgen Konaryev, Vice President/Dir.; Jae Ho Kim, Vice President/Dir.; Eugene Kron, Vice President Address 47 Redwillow Drive Toronto Ont. M3A 2K8 Canada Phone Number 416-662-1092 Fax Number 416-391-3802 Website URL http://www.control24.114toronto.com/ Email Address control24*114toronto.com SEC Filings » PMCL SEC Edgar filings PMCL News » Pharm Control Shareholder Update » Pharm Control Announces New Product Developmen... -------------------------------------------------------------------------------- ----------------------------------------- http://www.marketwire.com/mw/release_html_pressroom?id=604736DA9212FD68&release_ id=245033 Pharm Control Shareholder Update NEW YORK, NY -- (MARKET WIRE) -- April 27, 2007 -- Pharm Control (PINKSHEETS: PMCL) would like to update its shareholders by advising that the Company anticipates the name change to Natural Medications Inc., the new CUSIP and new symbol to be processed by some time in early May 2007. In addition, the Board of Directors increased the Authorized Shares to 1 billion in order to have the flexibility of possible financings in the future but also to pursue acquisitions, particularly manufacturing facilities in Southeast Asia. As part of this potential growth, the Company is looking into listing the Company for trading in overseas markets with an emphasis on South East Asia. About Pharm Control Ltd. Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world. Safe Harbor Statement The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
Contact: Pharm Control Ltd. Eugene Kron Vice President Email: pmclinfo*yahoo.com Tel: (212) 252-4521 SOURCE: Pharm Control Ltd.
================================================================================ ========================================== Dr Sang Hee Lee http://bric.postech.ac.kr/biotrend/scientist/scientist_detail.php?nNum=1343&nSID =4384 -------------------------------------------------------------------------------- ------------------------------------------ http://www.academicjournals.net/2/eb.php?id=2&theme=2&jid=jm Research Journal of Microbiology Editor-in-Chief Dr. Sang Hee Lee -------------------------------------------------------------------------------- ------------------------------------------ http://www.liebertonline.com/doi/abs/10.1089/mdr.2004.10.224?cookieSet=1&journal Code=mdr -------------------------------------------------------------------------------- ------------------------------------------ http://home.pusan.ac.kr:8000/~ecology/member.php -------------------------------------------------------------------------------- ------------------------------------------ [url= http://translate.google.com/translate?hl=en&sl=ko&u=http://bric.postech.ac.kr/bi otrend/scientist/scientist_detail.php%3FnNum%3D1343%26nSID%3D4384&sa=X&oi=transl ate&resnum=19&ct=result&prev=/search%3Fq%3D%2B%2522Dr%2BSang%2BHee%2BLee%2522%26 num%3D30%26hl%3Den%26lr%3D%26rlz%3D1T4TSHA_en___US207%26sa%3DG%26as_qdr%3Dall]ht tp://translate.google.com/translate?hl=en&sl=ko&u=http://bric.postech.ac.kr/bi otrend/scientist/scientist_detail.php%3FnNum%3D1343%26nSID%3D4384&sa=X&oi=transl ate&resnum=19&ct=result&prev=/search%3Fq%3D%2B%2522Dr%2BSang%2BHee%2BLee%2522%26 num%3D30%26hl%3Den%26lr%3D%26rlz%3D1T4TSHA_en___US207%26sa%3DG%26as_qdr%3Dall[/u rl] -------------------------------------------------------------------------------- ------------------------------------------
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
(.0145 +.003) Pharm Control Shareholder Update Friday May 11, 9:45 am ET
NEW YORK, NY--(MARKET WIRE)--May 11, 2007 -- The Board of Directors of Pharm Control Ltd. (Other OTC:PMCL.PK - News) is proud to announce that they have decided to reward patient shareholders with a forward stock split whereby shareholders of record on June 29, 2007 will receive eight (8) new shares for every five (5) shares they hold. ADVERTISEMENT
The company intends to proceed with the previously announced stock spin-off of the European distribution company after this dividend is completed.
Pharm Control Ltd. is still in the process of completing its change of transfer agents while awaiting the approval of the new stock symbol by the NASD.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
Contact:
Pharm Control Ltd.
Eugene Kron
Vice President
Email: pmclinfo*yahoo.com
Tel: (212) 252-4521
SOURCE: Pharm Control Ltd.
CONTACT: mailto:pmclinfo*yahoo.com
Copyright 2007 Market Wire, All rights reserved.
-0-
SUBJECT CODE: Medical and Healthcare:Alternative
Medical and Healthcare:Facilities and Providers
Pharmaceuticals and Biotech:Trials
Medical and Healthcare:Medical Devices
Medical and Healthcare:Surgery and Treatments
Medical and Healthcare:Health and Nutrition
Source: Comtex Wall Street News -------------------------------------------------
okidoki ~ couple questions will the spin off be under the same symbol or a different one and will they be restricted?
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Latest News Headlines for PHARM CONTROL LTD redhotpennystock.com: PMCL, RGNO, RMDN, MBKR "Red Hot Penny Stock Alert" Friday 05/11/2007 11:17 AM ET - M2 Bull in Advantage, LLC a.k.a. Redhotpennystock.com names Pharm Control Ltd. (Pink Sheets: PMCL), Regions Oil & Gas, Inc. (Pink Sheets: RGNO) RMD Entertainment Group (Pink Sheets: RMDN) and MortgageBrokers.com Holdings Inc. (OTCBB: MBKR) its "Red Hot Penny Stock."
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
(.0115) Pharm Control Shareholder Update Wednesday May 16, 4:30 pm ET
NEW YORK, NY--(MARKET WIRE)--May 16, 2007 -- The Board of Directors of Pharm Control Ltd. (Other OTC:PMCL.PK - News) has decided to dividend out to shareholders one new share of Natural Medicines AG for every three shares of Pharm Control Ltd. held by shareholders of record on Friday, July 13, 2007. ADVERTISEMENT
Discussions with European investment bankers have revealed to Company management that the anticipated trading level for the new European entity will be in the area of 0.25 Euros.
This dividend will be paid after the 8 new for 5 old dividend payment of Pharm Control Ltd. at the end of June.
Pharm Control Ltd.'s management anticipates the name change and CUSIP number change to become effective any day now and will follow up with another shareholder update along with the name of the new transfer agent once all is completed.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
Contact: Contact: Pharm Control Ltd. Eugene Kron Vice President Email: pmclinfo*yahoo.com Tel: (212) 252-4521
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Posted by: Anthony1971 In reply to: None Date:5/16/2007 5:35:57 PM Post #of 24443
Here is an example for everyone. Check it out$$
Your shares divided by 5 X 8 will be your new share count after June 29th Then! Divide that number by 3 and that is your dividend shares X's $.34!!! OMG!!
Example 100,000 shares divided by 5 X 8 160,000 divided by 3 is 53,333 x's $.34 Your dividend is worth $18,133
I hope this helps people!
Posts: 712 | From: Pungo USA | Registered: Mar 2006
| IP: Logged |
quote:Originally posted by kilikili: Posted by: Anthony1971 In reply to: None Date:5/16/2007 5:35:57 PM Post #of 24443
Here is an example for everyone. Check it out$$
Your shares divided by 5 X 8 will be your new share count after June 29th Then! Divide that number by 3 and that is your dividend shares X's $.34!!! OMG!!
Example 100,000 shares divided by 5 X 8 160,000 divided by 3 is 53,333 x's $.34 Your dividend is worth $18,133
I hope this helps people!
a diluted share increase will add to the pps? Did you read this before you posted? same as a FS. no restrictions advertised (ie preferred or by class) nor were any benies advertised. same with the pr for the july spinoff. there is nothing to gain other than more shares so far. and the insiders get the same math.... which could make it more appetizing for a rs. when you do your math you should include the total OS not just your holdings. just my opinion.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
I think he was just figuring out the math with the numbers stated in the PR:
"dividend out to shareholders one new share of Natural Medicines AG for every three shares of Pharm Control Ltd."
"This dividend will be paid after the 8 new for 5 old dividend payment of Pharm Control Ltd. at the end of June."Posts: 712 | From: Pungo USA | Registered: Mar 2006
| IP: Logged |
posted
roger that kilikili. I'm not expecting anything out of this but would like to see something! you never know. keep in mind the fine print is yet to follow imo. restricted for how long? still a few bugs to work out imo.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
quote:Originally posted by T e x: up 47% as I type, .016 x .0165, off HOD of .018... purdy nice
trying not to jynx it
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Added to my position. Many big events heading our way imo. The ball is rolling...
Posts: 712 | From: Pungo USA | Registered: Mar 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Wink]](wink.gif)
![[Eek!]](eek.gif)
![[Big Grin]](biggrin.gif)
![[Smile]](smile.gif)
